DIRECTOR OF DEVELOPMENT - 
BLAIR GORDON, PhD

CEO - PAR NIJHAWAN, MD, FRCPC, AGAF

VICE PRESIDENT, CORPORATE DEVELOPMENT - 

MICHAEL BROOKS PhD, MBA

who we are

Dr. Gordon is responsible for the design, management and execution of Edesa’s clinical programs. He completed his PhD studies at the University of Toronto in the Department of Molecular Genetics where he was an NSERC Alexander Graham Bell Fellow. His previous roles include Business Development at Cipher Pharmaceuticals (TSX:CPH) and Medical Affairs at ArcticDX. Dr. Gordon is excited to be commercializing scientific discoveries at Edesa. 

Dr. Nijhawan is a board certified Gastroenterologist and Hepatologist. Prior to founding Edesa, Dr. Nijhawan was the CEO of Medical Futures Inc. which he sold to Tribute Pharmaceuticals in 2015. Dr Nijhawan completed his medical school training at the University of Ottawa and did his residency in Internal Medicine Internship at Yale-Norwalk, CT; and Internal Medicine residency and Gastroenterology and Hepatology fellowship at the Mayo Clinic in Rochester, MN.

Dr. Brooks has been Vice President of Corporate Development and Strategy at Edesa since 2015. He has responsibility for all corporate and business development activities including building Edesa’s product portfolio, growth through M&A, maximizing the value Edesa’s assets through development of commercial partnerships in markets outside North America and corporate finance. Prior to Edesa, he spent a number of years at Cipher Pharmaceuticals, (TSX:CPH), most recently as Director of Business Development. Michael holds an PhD from the University of Toronto and an MBA from the Rotman School of Management at U of T where he was a CIHR Science to Business Scholar.